BrendaJWittmanMD

Pediatric Hematology & Oncology • Anchorage, AK

Assistant Professor, Pediatrics, University of Arizona College of Medicine

Join to view full profile

Dr. Wittman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wittman's full profile

Already have an account?

Office
3340 Providence Dr
Suite A351
Anchorage, AK 99508
Phone+1 907-212-4824

Fax+1 425-917-9141

Education & Training

University of Rochester Medical CenterFellowship, Pediatric Hematology/Oncology, 2002 - 2005
University of Rochester Medical CenterResidency, Pediatrics, 1999 - 2002
University of Rochester School of Medicine and DentistryClass of 1999

Certifications & Licensure

AK State Medical License 2014 - 2026
AZ State Medical License 2005 - 2015
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
ACTIVE_NOT_RECRUITING
PHASE3
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
ACTIVE_NOT_RECRUITING
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor Start of enrollment: 2009 Jul 13
Active, not recruiting
Phase 3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
ACTIVE_NOT_RECRUITING
PHASE3
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
ACTIVE_NOT_RECRUITING
PHASE3
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Start of enrollment: 2019 Jul 03
ACTIVE_NOT_RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

4 citations
Is Identification of Lupus Erythematosus Cells Still Useful? A Case Report
Min Xu, Lucinda A MacNeal, Brenda J Wittman, Joe C. Rutledge
Pediatric and Developmental Pathology. 2016-11-01
34 citations
Late effects in adult survivors of pediatric cancer: a guide for the primary care physician.
Lisa M. Kopp, Puja Gupta, Luz Pelayo-Katsanis, Brenda Wittman, Emmanuel Katsanis
The American Journal of Medicine. 2012-07-01
37 citations
Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials.
Brenda Wittman, John T. Horan, Gary H. Lyman
Cancer Treatment Reviews. 2006-06-01